Critical Limb Ischemia and Transcutaneous Oximetry (CITRA)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04369781|
Recruitment Status : Recruiting
First Posted : April 30, 2020
Last Update Posted : May 4, 2020
|Condition or disease||Intervention/treatment|
|Critical Limb Ischemia||Diagnostic Test: transcutaneous oxygen pressure recording at rest|
- Patients had Tcpo2 recording at the suspected limb and chest level at rest in the lying position.
- Provocative tests (leg elevation, leg lowering, oxygen inhalation) were performed to improve the sensitivity of tests.
- TcpO2 results were recorded on a 1 Hz bais for of line analysis after anonymization.
- We recorded age , gender, weight, height, ongoing treatments , History of cardiac or respiratory disease.
Visual and mathematical analysis of the TcpO2 recording at the chest and limb level searching for various indices of TcpO2 variability at rest, or differences in responses between the chest and limb tcpO2 responses to provocative tests..
|Study Type :||Observational [Patient Registry]|
|Estimated Enrollment :||300 participants|
|Target Follow-Up Duration:||4 Years|
|Official Title:||Oximetrie Transcutanee et Ischemie Critique|
|Actual Study Start Date :||October 15, 2018|
|Estimated Primary Completion Date :||October 2022|
|Estimated Study Completion Date :||October 2022|
Suspected critical limb ischemia
Patients referred for transcutaneous oxygen pressure measurements due to a clinical suspicion of critical limb ischemia
Diagnostic Test: transcutaneous oxygen pressure recording at rest
Recording of limb and chest transcutaneous oxygen pressure
- Variability of TcpO2 [ Time Frame: 1 hour ]Study of TcpO2 variability
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04369781
|Contact: Pierre ABRAHAM, MD PhDfirstname.lastname@example.org|
|Contact: Pierre ABRAHAM|
|Principal Investigator:||Pierre ABRAHAM, MD; PhD||University and univerity hospital in Angers, FRANCE|